Hirotaka Sekiguchi Selected Research

Alzheimer Disease (Alzheimer's Disease)

2/2011

Clinicopathological study of diffuse neurofibrillary tangles with calcification. With special reference to TDP-43 proteinopathy and alpha-synucleinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirotaka Sekiguchi Research Topics

Disease

7	Schizophrenia (Dementia Praecox) 12/2019 - 10/2010
3	Mental Disorders (Mental Disorder) 12/2018 - 10/2010
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 02/2011
2	Fatty Liver 09/2021 - 03/2019
2	Disease Progression 01/2017 - 02/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016 - 01/2016
2	Fibrosis (Cirrhosis) 12/2016 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2010 - 09/2008
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2021
1	Autistic Disorder (Autism) 12/2018
1	Rupture 01/2018
1	Amnesia (Dissociative Amnesia) 09/2017
1	Dementia (Dementias) 09/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 09/2017
1	Sleep Wake Disorders 09/2017
1	Necrosis 12/2016
1	Cognitive Dysfunction 12/2016
1	Siderosis 12/2016
1	Hallucinations (Hallucination) 12/2016
1	Treatment-Resistant Schizophrenia 02/2013
1	Gastritis 07/2012
1	Atrophy 02/2011
1	Amyloid Plaque 02/2011
1	Diffuse Neurofibrillary Tangles with Calcification 02/2011
1	Alzheimer Disease (Alzheimer's Disease) 02/2011
1	Body Weight (Weight, Body) 10/2010
1	Starvation 01/2010

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2008
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2017 - 10/2010
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023 - 12/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2016
2	auraptenIBA 07/2012 - 01/2010
1	Cardiolipins (Cardiolipin)IBA 09/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2021
1	Mazindol (Mazanor)FDA Link 12/2019
1	Desipramine (Pertofrane)FDA LinkGeneric 12/2019
1	NucleotidesIBA 03/2019
1	Amino Acids FDA Link 12/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 08/2018
1	Nicotine FDA Link 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 09/2017
1	Neuropeptide YIBA 04/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	CollagenIBA 12/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2016
1	Nucleic AcidsIBA 12/2016
1	Ethanol (Ethyl Alcohol)IBA 12/2016
1	gamma-Aminobutyric Acid (GABA)IBA 12/2016
1	HemosiderinIBA 12/2016
1	XenobioticsIBA 01/2016
1	AntioxidantsIBA 01/2016
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2016
1	Concanavalin AIBA 01/2016
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2016
1	CationsIBA 01/2016
1	Olanzapine (Zyprexa)FDA Link 02/2013
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2011
1	4- N,N- dimethylamino- 1- naphthylisothiocyanateIBA 02/2011
1	IsoflavonesIBA 10/2010
1	UreaseIBA 01/2010
1	coumarinIBA 01/2010
1	Phosphotransferases (Kinase)IBA 01/2010
1	PhytochemicalsIBA 09/2008
1	Messenger RNA (mRNA)IBA 09/2008

Therapy/Procedure

1	Phototherapy (Light Therapy) 09/2017
1	Therapeutics 09/2017